RegWardenFDA facility compliance records
Recall

Class II — Implant Direct Sybron Manufacturing LLC

Recalling firmImplant Direct
Registered facilityIMPLANT DIRECT SYBRON MANUFACTURING LLC (the firm's only registered facility)
ClassificationClass II
StatusTerminated
ReasonDue to a complaint received and internal investigation it was determined that implant vials were distributed with incorrect color coded vials and caps. The part/lot numbers were correct, the customer received the product they ordered, however the color on the vial label and cap labels were incorrect.Specifically, the color coded vial and cap does not match the implant size described on the vial. As a result of the incorrect color on the vial and cap, the surgeon may not be certain if the implant received was the correct size. This could result in a delay in surgery, risk of infection if the surgical site has to be closed up and a second round of anesthesia.
ProductSwishPlus Implant 5.7mmD x 8mmL, SBM 6.5mmD Platform, Part Number 925708
Quantity11 units
DistributionUS: None OUS: Iceland, Sweden, Spain,
Initiated2019-01-09
Classified2020-02-10
Terminated2021-04-27
Recall numberZ-1126-2020
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — Implant Direct Sybron Manufacturing LLC (Z-1126-2020).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/84706/

Not open yet

Alerts for Implant Direct

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.